Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis

The Journal of Clinical Investigation
B M Mueller, W Ruf

Abstract

Tissue factor (TF), the initiating cell surface receptor of the coagulation cascade, plays important roles in embryogenesis, angiogenesis, and tumor cell metastasis. It is controversial whether proteolytic function of TF complexed with its serine protease ligand VIIa is required for metastatic tumor dissemination. We show here in a model for TF-dependent experimental hematogenous metastasis, that TF supports metastasis by both proteolytic activity of the TF-VIIa complex and currently undefined functions of the cytoplasmic domain. We demonstrate that ligand binding of VIIa to TF is required for metastasis. Antimetastatic properties of covalently inactivated VIIa provide evidence that ligand binding is insufficient per se to support metastasis, emphasizing that proteolytic activity is necessary for the metastatic process. Ala or Asp mutations of cytoplasmic serine residues were introduced to preclude or mimic phosphorylation. In vivo analysis of these mutants suggests that local protease generation on the tumor cell surface does not serve simply to activate the cytoplasmic domain of TF by serine phosphorylation. Thus, extracellular functions of the catalytically active TF-VIIa complex cooperate with specific functions of the TF c...Continue Reading

References

Dec 4, 1992·Annals of the New York Academy of Sciences·V EllisK Danø
Nov 1, 1992·Cancer Metastasis Reviews·L V Rao
Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·B M MuellerW Ruf
Sep 1, 1994·The Journal of Clinical Investigation·Y ZhangP P Nawroth
Aug 29, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E BrombergA Garen
May 1, 1994·The Journal of Experimental Medicine·G GrandalianoH E Abboud
Mar 1, 1996·Arteriosclerosis, Thrombosis, and Vascular Biology·M J RabietE Dejana
Jun 25, 1996·Proceedings of the National Academy of Sciences of the United States of America·T H BuggeJ L Degen
Sep 5, 1996·Nature·P CarmelietD Collen
Dec 1, 1995·Cancer Metastasis Reviews·A F ChambersA C Groom
Oct 1, 1996·Current Opinion in Cell Biology·J A Varner, D A Cheresh
Oct 1, 1996·Haemostasis·V FusterJ T Fallon
May 2, 1997·The Journal of Biological Chemistry·B B SorensenL V Rao
Sep 1, 1996·Current Opinion in Hematology·W Ruf, B M Mueller

❮ Previous
Next ❯

Citations

Jun 2, 2000·Biochemical and Biophysical Research Communications·A S WolbergM Hoffman
Feb 3, 2006·Cancer Immunology, Immunotherapy : CII·Chao LiCamille Ettelaie
Feb 26, 2008·Cancer Immunology, Immunotherapy : CII·Chao LiCamille Ettelaie
Jun 13, 2008·International Journal of Colorectal Disease·Jian-Quan ZhangYi-Sheng Pan
Jul 31, 2009·Clinical & Experimental Metastasis·Susan Blaydes IngersollAli Amirkhosravi
Jun 25, 2004·The American Journal of Pathology·Laveena SharmaPeter G Tipping
Jul 24, 2002·Clinical Biochemistry·Ming GuanYuan Lu
Nov 21, 2007·Thrombosis Research·Wolfram Ruf
Jun 26, 2003·Trends in Pharmacological Sciences·John H McVey
Jan 11, 2001·Trends in Cardiovascular Medicine·L C PetersenM Ezban
Jun 20, 2001·Trends in Cardiovascular Medicine·L V Rao, U R Pendurthi
Dec 1, 2001·Trends in Cardiovascular Medicine·T Luther, N Mackman
Dec 1, 2001·Trends in Cardiovascular Medicine·M P Peppelenbosch, H H Versteeg
Jul 23, 2008·Seminars in Thrombosis and Hemostasis·Rafal Pawlinski, Nigel Mackman
Jul 29, 2008·The Journal of Biological Chemistry·Erin M ConnJames P Quigley
Jul 16, 2004·Molecular Biology of the Cell·Andrea DorfleutnerWolfram Ruf
Jun 13, 2000·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·L V Rao, M Ezban
Jun 23, 2000·Journal of Pediatric Hematology/oncology·J S Palumbo, J L Degen
Feb 23, 2008·Clinical and Experimental Pharmacology & Physiology·Darren R Davis, Jonathan H Erlich
Feb 22, 2008·Journal of Veterinary Internal Medicine·A T KristensenA L Jensen
Feb 18, 2004·Molecular and Cellular Biology·Michelle A BoodenJoAnn Trejo
Dec 1, 2004·Arteriosclerosis, Thrombosis, and Vascular Biology·L Vijaya Mohan Rao, Usha R Pendurthi
Aug 8, 2009·Arteriosclerosis, Thrombosis, and Vascular Biology·Florence Schaffner, Wolfram Ruf
Jun 7, 2000·The Journal of Clinical Investigation·G C Parry, N Mackman
Sep 29, 2007·Blood·Henri H VersteegWolfram Ruf
Jun 23, 2005·Journal of Translational Medicine·Xipeng WangRalph S Freedman
Apr 1, 2008·Breast Cancer Research : BCR·Joanne E BluffCarolyn A Staton
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicole M KudererCharles W Francis
Sep 10, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Raj S KasthuriNigel Mackman
May 11, 2010·Molecular Medicine·Zhi XuFrancis J Castellino
Aug 2, 2011·American Journal of Veterinary Research·Tracy StokolSungkwon Kang
Aug 21, 2001·Biochemical and Biophysical Research Communications·E MelisM Dewerchin
Jul 5, 2001·Proceedings of the National Academy of Sciences of the United States of America·M Riewald, W Ruf
Jul 21, 1999·Proceedings of the National Academy of Sciences of the United States of America·K AbeF R Rickles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.